Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. NTES

Go back to Merck Provides Regulatory Update on Investigational Medicine Sugammadex Injection
Merck & Co. (NYSE: MRK) Delayed: 148.99 -3.21 (2.11%)
Previous Close $152.20    52 Week High $65.46 
Open $150.78    52 Week Low $47.97 
Day High $152.52    P/E 101.35 
Day Low $148.52    EPS $1.47 
Volume 16,441,653